Peek behind the paper: High-throughput multiomic approaches in the COVID-19 pandemic

In this interview, Rwik Sen (Active Motif, CA, USA) speaks about his recent work published in Future Drug Discovery on the use of metabolomic, proteomic and other approaches to establish processes for diagnosis and therapeutic development for COVID-19.  Rwik is a Field Applications Scientist at Active Motif – known for its expertise in epigenetics for over two decades, perfectly aligning with Rwik’s interests. He attended Southern Illinois University (IL, USA) for a PhD, and the University of Colorado (CO, USA) for postdoctoral training where he received a fellowship from the American Heart Association. Collectively, Rwik’s research on transcription, mRNA biology,...